CA
CELG

Clearstead Advisors’s Celgene Corp CELG Stock Holding History

Clearstead Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,706
Closed -$765K – 290
2019
Q3 		$765K Sell
7,706
-675
-8% -$64.1K 0.1% 133
2019
Q2 		$775K Buy
8,381
+1,405
+20% +$133K 0.1% 134
2019
Q1 		$658K Sell
6,976
-113
-2% -$9.88K 0.09% 143
2018
Q4 		$454K Sell
7,089
-2,154
-23% -$159K 0.07% 169
2018
Q3 		$827K Sell
9,243
-694
-7% -$61.3K 0.11% 119
2018
Q2 		$789K Buy
9,937
+268
+3% +$22.3K 0.11% 117
2018
Q1 		$863K Buy
9,669
+625
+7% +$60K 0.13% 118
2017
Q4 		$944K Sell
9,044
-973
-10% -$110K 0.13% 110
2017
Q3 		$1.46M Sell
10,017
-172
-2% -$23.4K 0.19% 93
2017
Q2 		$1.32M Buy
10,189
+686
+7% +$84.1K 0.19% 92
2017
Q1 		$1.18M Buy
9,503
+4,238
+80% +$507K 0.17% 92
2016
Q4 		$609K Buy
+5,265
New +$586K 0.1% 119

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Clearstead Advisors's CELG Position: Q4 2019 in Review

Clearstead Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,706 shares — an estimated $765K sold.

Clearstead Advisors first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $1.46M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Clearstead Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Clearstead Advisors sold 7,706 Celgene Corp shares in Q4 2019, an estimated $765K.
  • Clearstead Advisors first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Clearstead Advisors's Celgene Corp position peaked at $1.46M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Clearstead Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.